Advertisement

The Assessment of Drugs Acting on Interstitial Lung Diseases

  • R. K. Knight
Part of the Ettore Majorana International Science Series book series (EMISS, volume 14)

Abstract

There are many causes of interstitial lung disease. I will consider the methods that have been developed and evaluated to assess and follow patients with cryptogenic fibrosing alveolitis with some reference to sarcoidosis. The techniques used in these conditions can be widely applied to other conditions as appropriate.

Keywords

Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Interstitial Lung Disease Migration Inhibition Factor Lung Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Klassen, K. P., Anylan, A. J. and Curtis, G. M., (1949) Biopsy of diffuse pulmonary lesions. Archives of Surgery, 59, 694–704.CrossRefGoogle Scholar
  2. 2.
    Knight, R. K. (1981). Bronchoscopy and other biopsy techniques. In: Thoracic Medicine (Butterworths), 189–219.Google Scholar
  3. 3.
    Steel, S. J. and Winstanley, D. P. (1967). Trephine biopsy for d if f use lung lesions. British Medical Journal, 3, 30–32.CrossRefGoogle Scholar
  4. 4.
    Wright, P. H., Heard, B. E., Steel, S. J., Turner-Warwick, M. T. (1981). Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features. British Journal of Diseases of the Chest, 75, 61–70.CrossRefGoogle Scholar
  5. 5.
    Carrington, C. B., Gaensler, D. A., Coutu, R. E., Fitzgerald, N.X., Gupta, R. G. (1978). Natural history and treated cause of usual and desquamative interstitial pneumonia. The New England Journal of Medicine, 298, 801–809.CrossRefGoogle Scholar
  6. 6.
    Turner-Warwick, M., Burrows, B., Johnson, A. (1980). Cryptogenic fibrosing alveolitis: response to corticosteroid therapy and its effect on survival. Thorax, 35, 593–599.CrossRefGoogle Scholar
  7. 7.
    Turner-Warwick, M., Burrows, B., Johnson, A. (1980). Cryptogenic f4ibrosing alveolitis: clinical features and their influence on survival. Thorax, 35, 171–180.CrossRefGoogle Scholar
  8. 8.
    Shirai, F., Kudoh, S., Shibuya, A., Sada, K., Mikami, R. (1981). Crackles in asbestos workers: auscultation and lung sound analysis. British Journal of Diseases of the Chest, 75, 386–396.CrossRefGoogle Scholar
  9. 9.
    UICC Committee. (1970). Cincinnati classification of the radiographic appearances of pneumoconiosis: a co-operative study by the UICC Committee. Chest, 58, 57–67.CrossRefGoogle Scholar
  10. 10.
    Cole, P., Turton, C., Lanyon, H., Collins, J. (1980). Bronchoalveolar lavage for the preparation of free lung cells: techniques and complications. British Journal of Diseases of the Chest, 74, 273–278.CrossRefGoogle Scholar
  11. 11.
    Line, B. R., Fulmer, J. D., Reynolds, H. Y., Roberts, W. C., Jones, A. E., Harris, E. K., Crystal, R. G. (1978). Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation with physiologic and morphologic features and bronchoalveolar lavage. American Review of Respiratory Disease, 118, 355–365.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • R. K. Knight
    • 1
  1. 1.Brompton Hospital FrimleyCamberley, SurreyUK

Personalised recommendations